HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoji Uchida Selected Research

Adalimumab (Humira)

5/2014Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial.
3/2014Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoji Uchida Research Topics

Disease

3Rheumatoid Arthritis
05/2014 - 02/2004

Drug/Important Bio-Agent (IBA)

2Adalimumab (Humira)FDA Link
05/2014 - 03/2014
1Methotrexate (Mexate)FDA LinkGeneric
05/2014
1Monoclonal AntibodiesIBA
03/2014
1Tacrolimus (Prograf)FDA LinkGeneric
02/2004
1Antirheumatic Agents (DMARD)IBA
02/2004

Therapy/Procedure

1Therapeutics
02/2004